Gilead Sciences, Inc.
Phosphatidylinositol 3-kinase inhibitors

Abstract:

The present application provides the compounds of formula I ##STR00001## or pharmaceutically acceptable salts, isomers, tautomer, or a mixture thereof, wherein t, R.sup.1, R.sup.2, R.sup.3, R.sup.4, and R.sup.6 are as described herein.